Back to List

Regulations for Registration of Medicinal Products - Article 76-3

Regulations for Registration of Medicinal Products|第 76-3 條|Food and Drug Administration|Regulation|In Force

第 三 章/第 一 節|衛生福利部|v1.0

Effective Date: 2024-01-01|Last Amended: 2023-04-27

Content

A Chinese medicine product is named in Chinese or a foreign language: 1. Chinese: No combination with foreign letters or Arabic numerals is allowed, unless they directly convey a meaning. 2. Foreign languages: They may be translated from Chinese by means of transliteration or semantic translation. Up to three product names, as set forth in the preceding paragraph, shall be provided for the central health competent authority to approve one of them. Chinese medicine product names that are used for export only shall not be subject to the quantitative limitation set forth in the preceding paragraph if they are directly transliterated from Chinese. However, if such names are not directly transliterated from Chinese, no more than three names shall be approved for each application.

Related Regulations - Regulations for Registration of Medicinal Products

  • Regulations for Registration of Medicinal Products - Article 70(第 70 條)
  • Regulations for Registration of Medicinal Products - Article 81(第 81 條)
  • Regulations for Registration of Medicinal Products - Article 74(第 74 條)
  • Regulations for Registration of Medicinal Products - Article 75(第 75 條)
  • Regulations for Registration of Medicinal Products - Article 76(第 76 條)
  • Regulations for Registration of Medicinal Products - Article 76-1(第 76-1 條)
  • Regulations for Registration of Medicinal Products - Article 76-2(第 76-2 條)